Evosep at ASBMB 2025

We are thrilled to participate at the annual Conference of the 15th international symposium on proteomics in the life sciences, which will take place in Cambridge, Mass., US on August 17 – 21, 2025. Please visit us at our booth, where will be happy to introduce you to our technology and how we can contribute with fully automated and standardized workflows. You are also welcome to join our Evosep Lunch Seminar, register and secure your seat now.

Monday, August 18th, 2025: 12:30 – 2:00 PM – Room: The Broad Institute auditorium

ASBMB 2025 lunch seminar

Join our symposium and get the newest data of proteomics workflows, scientific discussions, and new discoveries from Evosep. Learn more about the full programme at ASBMB 2025.

Monday, August 18th, 2025: 12:30 – 2:00 PM – Room: The Broad Institute auditorium

ASBMB 2025 lunch seminar

Join our symposium and get the newest data of proteomics workflows, scientific discussions, and new discoveries from Evosep. Learn more about the full programme at ASBMB 2025.

Register

The SPEC universal sample preparation method and its applications

Talk by Prof. Matthias Mann, Director at Max Planck Institute for Biochemistry & Director at
Novo Nordisk Foundation for Protein Research

Sample preparation remains one of the least standardized yet most influential steps in MS-based proteomics. Our recently developed SPEC protocol provides a universal, tip-based platform that integrates protein capture, cleanup, and chemical derivatization in a single solid-phase workflow. SPEC accommodates diverse input types—from cells and tissues to plasma—while enabling downstream innovations such as nanoPhos, an ultra-sensitive phosphoproteomics method. I will trace the evolution of proteomics sample preparation, highlighting how SPEC consolidates best practices into a robust, automation-ready format. Finally, I will discuss our outlook for SPEC, including integration with Evosep tips for scalable, reproducible, and high-throughput clinical and single-cell proteomics. By unifying sample prep across applications, SPEC lays the foundation for consistent, large-scale datasets critical to the next generation of proteomics.

Breaking Barriers in Proteomics: Next-Generation Workflows for Translational Research

Talk by Ann Reynolds, Senior Associate Scientist at Bristol Myers Squibb

Proteomics brings together science and technology with broad applications across drug discovery. Despite significant progress over the past decade, it still faces barriers to widespread adoption in biological and biopharma research. This presentation will showcase how advancements across the workflow—from sample preparation to next-generation LC-MS technologies and deep learning–based data analytics—are unlocking the full potential of proteomics and enabling actionable insights for drug discovery and translational research, with a focus on plasma and serum profiling as a case study for biomarker discovery.